Histogenics Products
Histogenics’ technology is designed to encourage generation and integration of true hyaline cartilage, unlike other methods of cartilage repair, making treatment more efficient and outcomes more successful.
Click to find out more about:
Advantages
Histogenics products use the patient’s own cells to grow articular cartilage. NeoCart is a three-dimensional, neocartilage implant grown from patient’s cells (chondrocytes) outside the body. At implantation in the patient, the cells have produced a hyaline cartilage-like matrix and there are still actively dividing cells which allow integration with the surrounding tissue. The VeriCart matrix allows cartilage cells to grow within its micropores at the site of the damage, either from the patient’s chondrocytes or mesenchymal stem cells added to the matrix.
Both products feature:
Intellectual property
Histogenics has a strong portfolio of tissue engineering patents, including three issued US patents and 13 published US patent applications on the structure and function of NeoCart® neocartilage and related products. It also has licensed three patents and 12 patent applications related to the use of high pressure and the tissue engineering processor, and extensive patent coverage for the bioglue component of its scaffolds.
Histogenics products are limited by federal law to investigational use and are not available for sale.
©2007 Histogenics Corporation